BIIB34:BVMF
Biogen Inc BDR
R$186.01
0.00%
(0.00) 1D
Okt 9, 4:56:00 PM GMT-3 · BRL
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa BIIB34...
Buksan
R$186.01
Mataas
R$186.01
Mababa
R$186.01
Mkt. cap
33.35B
Avg. na dami
7.00
Dami
1.00
Mataas nang 52-wk
R$191.00
Mababa nang 52-wk
R$128.69
Mga natitirang share
147.75M
Bilang ng mga empleyado
8K
Buksan
R$186.01
Mataas
R$186.01
Mababa
R$186.01
Mkt. cap
33.35B
Avg. na dami
7.00
Dami
1.00
Mataas nang 52-wk
R$191.00
Mababa nang 52-wk
R$128.69
Mga natitirang share
147.75M
Bilang ng mga empleyado
8K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
GuruFocus
·
1 araw ang nakalipas
Biogen Inc (BIIB) Shares Surge 3.3% -- What GF Score of 73 Tells Investors
Profile
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the treatment of neurological diseases. The company's primary products are dimethyl fumarate, diroximel fumarate, interferon beta-1a, peginterferon beta-1a, and natalizumab, all for the treatment of multiple sclerosis; nusinersen for the treatment of spinal muscular atrophy; omaveloxolone for the treatment of Friedreich's ataxia; tofersen for the treatment of ALS; and dimethyl fumarate for the treatment of severe plaque psoriasis. The company also produces 5 biosimilars and has collaborations with Genentech for several drugs.
The company is ranked 424th on the Fortune 500 and 845th on the Forbes Global 2000. Wikipedia
Tungkol sa Biogen Inc BDR
CEOChris Viehbacher
Mga Empleyado7.5K
Itinatag1978
HeadquartersCambridge, Massachusetts, Estados Unidos
Sektor-
Websitebiogen.com